Janux Therapeutics, Inc. (JANX) Operating income 2020–2025
Janux Therapeutics, Inc. (JANX) annual operating income history from SEC filings — each fiscal year as reported.
-$157.7MFY2025 · since FY2020: -$4.8M → -$157.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$157.7M | -59.5% |
| FY2024 | -$98.8M | -35.4% |
| FY2023 | -$73.0M | -8.8% |
| FY2022 | -$67.1M | -103.7% |
| FY2021 | -$32.9M | -579.9% |
| FY2020 | -$4.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice